my country's plant extracts call for national standards

Chinese patent medicine is frustrated by EU, while plant extract has a bright future Yesterday, the first International Symposium on the standardization of extracts of traditional Chinese medicine and plant medicine was held in Han The participants called for the establishment of a unified international standard for Chinese plant extracts as soon as possible to meet the needs of the international market This seminar is sponsored by China traditional Chinese medicine quality standard professional committee, and hosted by Wuhan Optical Valley Biological city It is attended by scientific research institutes and industry chambers of Commerce from traditional Chinese medicine and plant extract industries It is reported that plant extracts are substances with active ingredients extracted from natural plants Plant extract is the main raw material of plant medicine preparation, which can be used in nutrition supplement, health food, cosmetics, etc it is the core product of natural medicine health product market According to statistics, plant extracts are the main force in the export of traditional Chinese medicine Last year, the export volume of this field rose to US $801.5 billion, accounting for 41.92% of the total export volume of traditional Chinese medicine After the 7-year transition period of EU's "traditional botanical medicine registration procedure directive" ended on April 30 this year, due to the unsuccessful registration of Chinese patent medicine in China, Chinese patent medicine will leave the EU temporarily Industry insiders believe that the EU market as a large market for botanical drugs, the frustration of Chinese patent medicine or will create an opportunity for plant extracts At present, there are hundreds of plant extracts produced in China, among which Ginkgo biloba extract, green tea extract and ginseng extract have been produced and exported on a large scale These products have a large market share in western countries As a new industry, most plant extracts in China are lack of uniform standards Liu Zhanglin, vice president of China Chamber of Commerce for the import and export of health care products, said that China's production enterprises have always followed the customer standard, that is, to produce according to the requirements of customers Although the operation is simple, the disadvantages are obvious: once the customer raises an objection to the product quality, the production enterprise will be controlled by others, many enterprises have "suffered losses" and suffered losses At yesterday's seminar, a number of experts called on China to establish a unified international standard as soon as possible, and at the same time, to establish a complete and standardized industry standard system for more plant extract varieties by referring to international standards and adopting advanced inspection and detection technologies and methods.